AAAAAA
Results:
1-24
|
Results: 24
Authors:
Makris, M
Baglin, T
Dusheiko, G
Giangrande, PLF
Lee, CA
Ludlam, CA
Preston, FE
Watson, HG
Wilde, JT
Winter, M
Citation: M. Makris et al., Guidelines on the diagnosis, management and prevention of hepatitis in haemophilia, HAEMOPHILIA, 7(4), 2001, pp. 339-345
Authors:
Morris, ES
Hampton, KK
Nesbitt, IM
Preston, FE
Thomas, WEG
Makris, M
Citation: Es. Morris et al., The management of von Willebrand's disease-associated gastrointestinal angiodysplasia, BL COAG FIB, 12(2), 2001, pp. 143-148
Authors:
Greaves, M
Preston, FE
Citation: M. Greaves et Fe. Preston, Rebuttal to: Oral contraceptives and venous thromboembolism, THROMB HAEM, 85(5), 2001, pp. 932-934
Authors:
Watson, HG
Baglin, T
Laidlaw, SL
Makris, M
Preston, FE
Citation: Hg. Watson et al., A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarin, BR J HAEM, 115(1), 2001, pp. 145-149
Authors:
Walker, ID
Greaves, M
Preston, FE
Citation: Id. Walker et al., Investigation and management of heritable thrombophilia, BR J HAEM, 114(3), 2001, pp. 512-528
Authors:
Kitchen, S
Theaker, J
Preston, FE
Citation: S. Kitchen et al., Monitoring unfractionated heparin therapy: relationship between eight anti-Xa assays and a protamine titration assay, BL COAG FIB, 11(2), 2000, pp. 137-144
Authors:
Beauchamp, NJ
Makris, M
Preston, FE
Peake, IR
Daly, ME
Citation: Nj. Beauchamp et al., Major structural defects in the antithrombin gene in four families with type I antithrombin deficiency - Partial/complete deletions and rearrangementof the antithrombin gene, THROMB HAEM, 83(5), 2000, pp. 715-721
Authors:
Jennings, I
Kitchen, S
Cooper, PC
Rimmer, JE
Woods, TAL
Preston, FE
Citation: I. Jennings et al., Further evidence that activated protein C resistance affects protein C coagulant activity assays, THROMB HAEM, 83(1), 2000, pp. 171-172
Authors:
Rimmer, JE
Cooper, PC
Brookfield, CJ
Preston, FE
Makris, M
Citation: Je. Rimmer et al., Evaluation of a global screening assay for the investigation of the protein C anticoagulant pathway, CLIN LAB H, 22(6), 2000, pp. 351-354
Authors:
Hough, RE
Hampton, KK
Preston, FE
Channer, KS
West, J
Makris, M
Citation: Re. Hough et al., Recombinant VIIa concentrate in the management of bleeding following prothrombin complex concentrate-related myocardial infarction in patients with haemophilia and inhibitors, BR J HAEM, 111(3), 2000, pp. 974-979
Authors:
Visanji, JM
Seargent, J
Tahri, D
Croft, SA
Makris, M
Preston, FE
Peake, IR
Daly, ME
Citation: Jm. Visanji et al., Influence of the-675 4G/5G dimorphism of the plasminogen activator inhibitor 1 promoter on thrombotic risk in patients with factor V Leiden, BR J HAEM, 110(1), 2000, pp. 135-138
Authors:
Makris, M
Leach, M
Beauchamp, NJ
Daly, ME
Cooper, PC
Hampton, KK
Bayliss, P
Peake, IR
Miller, GJ
Preston, FE
Citation: M. Makris et al., Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S, BLOOD, 95(6), 2000, pp. 1935-1941
Authors:
Leach, M
Makris, M
Hampton, KK
Preston, FE
Citation: M. Leach et al., Spinal epidural haematoma in haemophilia A with inhibitors - efficacy of recombinant factor VIIa concentrate, HAEMOPHILIA, 5(3), 1999, pp. 209-212
Authors:
Jennings, I
Kitchen, S
Woods, TAL
Preston, FE
Citation: I. Jennings et al., Normalization does not improve between-laboratory agreement but may improve specificity of some assays for activated protein C resistance, BL COAG FIB, 10(7), 1999, pp. 451-453
Authors:
Preston, FE
Kitchen, S
Jennings, I
Woods, TAL
Citation: Fe. Preston et al., A UK national External Quality Assessment scheme (UK NEQAS) for molecular genetic testing for the diagnosis of familial thrombophilia, THROMB HAEM, 82(5), 1999, pp. 1556-1557
Authors:
Kitchen, S
Iampietro, R
Woolley, AM
Preston, FE
Citation: S. Kitchen et al., Anti Xa monitoring during treatment with low molecular weight heparin or danaparoid: Inter-assay variability, THROMB HAEM, 82(4), 1999, pp. 1289-1293
Authors:
Nesbitt, IM
Hampton, KK
Preston, FE
Peake, IR
Goodeve, AC
Citation: Im. Nesbitt et al., A common splice site mutation is shared by two families with different type 2N von Willebrand disease mutations, THROMB HAEM, 82(3), 1999, pp. 1061-1064
Authors:
Kitchen, S
Jennings, I
Woods, TAL
Preston, FE
Citation: S. Kitchen et al., Local calibration of International Normalised Ratio improves between laboratory agreement: Results from the UK National External Quality Assessment Scheme, THROMB HAEM, 81(1), 1999, pp. 60-65
Authors:
Morsdorf, S
Agnelli, G
Preston, FE
Wenzel, E
Citation: S. Morsdorf et al., Optimizing therapy with oral anticoagulants: Risk analysis and socio-economic aspects - Preface, SEM THROMB, 25(1), 1999, pp. 1-3
Authors:
Kitchen, S
Preston, FE
Citation: S. Kitchen et Fe. Preston, Standardization of prothrombin time for laboratory control of oral anticoagulant therapy, SEM THROMB, 25(1), 1999, pp. 17-25
Authors:
Mainwaring, CJ
Makris, M
Thomas, WEG
Hampton, KK
Preston, FE
Citation: Cj. Mainwaring et al., Mesenteric infarction due to combined protein C deficiency and prothrombin20210 defects, POSTG MED J, 75(890), 1999, pp. 742-743
Authors:
Kitchen, S
Cartwright, I
Woods, TAL
Jennings, I
Preston, FE
Citation: S. Kitchen et al., Lipid composition of seven APTT reagents in relation to heparin sensitivity, BR J HAEM, 106(3), 1999, pp. 801-808
A rapid method for haemophilia B mutation detection using conformation sensitive gel electrophoresis
Authors:
Hinks, JL
Winship, PR
Makris, M
Preston, FE
Peake, IR
Goodeve, AC
Citation: Jl. Hinks et al., A rapid method for haemophilia B mutation detection using conformation sensitive gel electrophoresis, BR J HAEM, 104(4), 1999, pp. 915-918
Authors:
Leach, M
Makris, M
Gleeson, DC
Preston, FE
Citation: M. Leach et al., Acute liver failure induced by alcohol and paracetamol in an HCV-infected haemophiliac, BR J HAEM, 103(3), 1998, pp. 891-893
Risultati:
1-24
|